Show simple item record

dc.contributor.authorNewbold, KL
dc.contributor.authorFlux, G
dc.contributor.authorWadsley, J
dc.date.accessioned2018-02-15T12:19:47Z
dc.date.issued2017-05
dc.identifier.citationClinical oncology (Royal College of Radiologists (Great Britain)), 2017, 29 (5), pp. 307 - 309
dc.identifier.issn0936-6555
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1104
dc.identifier.eissn1433-2981en_US
dc.identifier.doi10.1016/j.clon.2016.12.008en_US
dc.description.abstractThe management of early stage differentiated thyroid cancer (DTC) with low risk of recurrence has been the subject of much interest and investigation in the recent years. Locally advanced DTC and patients with a high risk of recurrent disease however needs further investigation. This short review will look at what constitutes high risk thyroid cancer, the definition of radioiodine refractory disease, the current management and areas of debate within this clinical setting.
dc.formatPrint-Electronic
dc.format.extent307 - 309
dc.languageeng
dc.language.isoeng
dc.subjectHumans
dc.subjectThyroid Neoplasms
dc.subjectIodine Radioisotopes
dc.subjectRisk
dc.titleRadioiodine for High Risk and Radioiodine Refractory Thyroid Cancer: Current Concepts in Management.
dc.typeJournal Article
dcterms.dateAccepted2016-12-13
rioxxterms.versionofrecord10.1016/j.clon.2016.12.008
rioxxterms.licenseref.startdate2017-05en_US
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfClinical oncology (Royal College of Radiologists (Great Britain))
pubs.issue5
pubs.notesNo embargo
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radioisotope Physics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radioisotope Physics/Radioisotope Physics (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radioisotope Physics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Radioisotope Physics/Radioisotope Physics (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume29en_US
pubs.embargo.termsNo embargo
icr.researchteamRadioisotope Physicsen_US
dc.contributor.icrauthorFlux, Glennen
dc.contributor.icrauthorMarsden,en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record